Together with recently published studies in stroke, [2]–[4] TBI, [12]–[14] and brain tumors, [7], [10], [11] our study provides further insights into the pathophysiology of GFAP release in neurological disorders, which is discussed below in detail. Here, GFAP is linked to brain neoplasm.